Introduction: Finasteride is one of the most common drugs used in androgenetic alopecia.
INTRODUCTION
Finasteride 1 mg is used successfully all over the world for the treatment of androgenetic alopecia in male pattern baldness [1] . It is approved in the USA and many other countries.
Various clinical trials have established finasteride's efficacy in adult men with predominant vertex, anterior and midscalp region [2, 3] . On average, less than 2% of patients show side effects to the drug [4] . dysfunction and decreased ejaculate volume.
These side effects were found in less than 0.5% of patients [11] .
To assess the huge difference [2, 11] 
RESULTS
Both the study group and controls were asked to answer the IIEF questionnaire anonymously to avoid any identity on sexual weakness. The Comparing the age-wise finasteride-consuming patients and the control group, there was no statistical difference between the groups regarding their sexual function in total IIEF score or in any of the five domains mentioned.
The age-controlled graphs (Fig. 1) 
DISCUSSION
The main mechanism in androgenetic alopecia is miniaturization of hair follicles from terminal to vellus hair [6] due to the effect of androgen, especially dihydrotestosterone. Testosterone is converted by 5 alpha reductase to 5 alpha dihydrotestosterone, which is five times more potent than testosterone [8] . This dihydrotestosterone binds to the androgen receptors of the genetically marked hair follicle and leads to miniaturization of that hair follicle. This also reduces the rate of hair growth [7] .
Finasteride is an azasteroid type 2 isoenzyme, 5 alpha reductase inhibitor, which inhibits dihydrotestosterone conversion from testosterone [8] . This type 2 isoenzyme is present in the hair follicles and its activity is important in controlling the end organ hyper-reactivity causing androgenetic alopecia [8] . Testosterone is responsible for sexual function after puberty, but not by dihydrotestosterone. Observation of eunuchs and prepubertal boys highlighted the role of testosterone in the induction of androgenetic alopecia [9] . Therefore, it is evident that finasteride should not cause any side effects, relating to sexual health, as there will be no decrease in the quantity or quality of the testosterone level. However, clinical trials conducted by Leyden et al. [10] and Kaufman et al. [2] resulted in 2% of patients experiencing sexual side effects such as the loss of libido, erectile dysfunction and decreased ejaculate volume [4] .
In this study, patients taking Finasteride 1 mg for androgenetic alopecia and the control group were provided with the IIEF questionnaire and their responses analyzed.
The results indicated that erectile and sexual function was not reduced compared to the controls. So, not only theoretically, finasteride was found to be a comparatively safe drug in this Indian male population. This study was conducted in the Indian context on the basis of the IIEF [5] and the European study by Tosti et al. [11] . The present study was limited to Indian patients. Further studies should be conducted in a multi-center, double-blind manner.
CONCLUSION
In both our study and the study conducted by
Tosti et al. [11] , sexual and erectile function of those subjects who were orally treated with finasteride was not reduced compared with their age-related controls.
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